封面
市场调查报告书
商品编码
1430035

元宇宙医疗保健市场规模:按技术、组件、应用程式、最终用户 - 区域展望、竞争策略、细分市场预测(~2033 年)

Metaverse in Healthcare Market Size- By Technology, By Component, By Application, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

出版日期: | 出版商: SPER Market Research Pvt. Ltd. | 英文 213 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计到 2033 年,医疗元宇宙市场规模将成长至 1,274.6 亿美元,预测期内复合年增长率为 29.61%。

元宇宙正在融合三个重要的技术趋势:人工智慧、扩增实境(AR)和虚拟实境(VR)。它们共同有潜力扩大全新的治疗选择、降低成本并显着改善患者的治疗效果。

COVID-19 的爆发促使研究人员探索超越实体诊所范围远端探望患者的方法。市场的成长也受到智慧型手机和穿戴式科技使用日益增加的影响。数位健康正在彻底改变医疗保健产业,并成为生物技术进步的根本和强大驱动力。

本报告调查了全球医疗保健元宇宙市场,并提供了市场概况、市场影响因素和市场机会分析、市场规模趋势和预测、各个细分市场和地区的详细分析、竞争形势和主要企业。我正在收集简介等。

目录

第一章简介

第二章调查方法

第三章执行摘要

第四章市场动态

  • 驱动因素、限制因素、机会与挑战分析
  • COVID-19 对市场的影响

第五章 市场变数与展望

  • SWOT分析
  • PESTEL分析
  • 波特五力分析
  • 热图分析

第六章 竞争形势

  • 製造地、销售区域、产品类型分布
  • 併购、联盟、产品发布、合作

第七章全球医疗保健元宇宙市场:按组成部分

  • 全球市占率及预测
  • 硬体
  • 服务
  • 软体

第八章全球医疗保健元宇宙市场:依科技分类

  • 全球市占率及预测
  • AI
  • AR/VR
  • 区块链
  • IoT
  • MR

第九章全球医疗保健元宇宙市场:依应用分类

  • 全球市占率及预测
  • 诊断
  • 医疗训练/教育
  • 远端医疗

第 10 章 全球医疗元宇宙市场:依最终使用者分类

  • 全球市占率及预测
  • 病人
  • 保险公司
  • 药局
  • 医疗提供者

第十一章 全球医疗元宇宙市场预测

  • 市场规模/市场占有率

第十二章全球医疗保健元宇宙市场:按组成部分

  • 市场规模/市场占有率趋势/预测

第十三章全球医疗保健元宇宙市场:依科技分类

  • 市场规模/市场占有率趋势/预测

第14章全球医疗保健元宇宙市场:依应用分类

  • 市场规模/市场占有率趋势/预测

第十五章全球医疗元宇宙市场:依最终用户分类

  • 市场规模/市场占有率趋势/预测

第十六章全球医疗保健元宇宙市场:按地区

  • 市场规模/市场占有率趋势/预测
  • 亚太地区
  • 欧洲
  • 中东/非洲
  • 北美洲
  • 拉丁美洲

第十七章 公司简介

  • Brain lab
  • Medtronic PLC
  • Meta Platforms
  • Microsoft Corporation
  • Nvidia Corporation
  • Roblox Corporation
  • Sesame
  • Siemens Healthineers
  • Veyond Metaverse
  • Zimmer Biomet Holdings
  • 其他的

第十八章简称表

第十九章 参考链接

第20章结论

第二十一章 研究范围

简介目录
Product Code: IACT2425

Metaverse In Healthcare Market Introduction and Overview

According to SPER market research, 'Metaverse in Healthcare Market By Technology, By Component, By Application, By End User -Regional Outlook, Competitive Strategies and Segment Forecast to 2033 'state that the Metaverse In Healthcare Market is predicted to reach USD 127.46 billion by 2033 with a CAGR of 29.61%.

The huge digital cosmos known as the meta-verse coexists with the physical world. All of the virtual worlds that individuals can engage with, socialize in, play games, and shop in make up the meta-verse. In the meta-verse (VR), three key technological trends-intellectual (AI), augmented reality (AR), and virtual reality (VR)-converge. When combined, they have the potential to open up whole new treatment options, reduce expenses, and significantly improve patient outcomes.

The COVID-19 pandemic acted as a spur for researchers to discover methods for remote patient supervision beyond the confines of physical clinics. Growth in the market has also been impacted by the growing use of smartphones and wearable technology. One significant element in this context is digital health, which is revolutionizing the healthcare industry and acting as a fundamentally potent push for biotechnology advancement.

Scope of the Report:

Report Metric Details

Market size available for years 2019-2033

Base year considered 2022

Forecast period 2023-2033

Segments covered By Component, By Technology, By Application, By End User

Regions covered North America, Asia-Pacific, Latin America, Middle East & Africa and Europe

Companies Covered Brain lab, Medtronic PLC, Meta Platforms, Microsoft Corporation, Nvidia Corporation, Roblox Corporation, Sesame, Siemens Healthineers, Veyond Metaverse, Zimmer Biomet Holdings

Metaverse In Healthcare Market Segmentation:

By Components: Based on the Components, Global Metaverse in Healthcare Market is segmented as Hardware, Services, Software.

By Technology: Based on the Technology, Global Metaverse in Healthcare Market is segmented as AR/VR, MR, AI, Blockchain, IoT.

By Application: Based on the Application, Global Metaverse in Healthcare Market is segmented as Tele-health, Diagnostics, Medical Training & Education.

By End-User: Based on the End-User, Global Metaverse in Healthcare Market is segmented as Provider, Patients, Payers, Pharmacy.

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1. Research data source
    • 2.1.1. Secondary Data
    • 2.1.2. Primary Data
    • 2.1.3. SPER's internal database
    • 2.1.4. Premium insight from KOL's
  • 2.2. Market size estimation
    • 2.2.1. Top-down and Bottom-up approach
  • 2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunities
    • 4.1.4. Challenges
  • 4.2. COVID-19 Impacts of the Global Metaverse In Healthcare Market

5. Market variable and outlook

  • 5.1. SWOT Analysis
    • 5.1.1. Strengths
    • 5.1.2. Weaknesses
    • 5.1.3. Opportunities
    • 5.1.4. Threats
  • 5.2. PESTEL Analysis
    • 5.2.1. Political Landscape
    • 5.2.2. Economic Landscape
    • 5.2.3. Social Landscape
    • 5.2.4. Technological Landscape
    • 5.2.5. Environmental Landscape
    • 5.2.6. Legal Landscape
  • 5.3. PORTER's Five Forces
    • 5.3.1. Bargaining power of suppliers
    • 5.3.2. Bargaining power of buyers
    • 5.3.3. Threat of Substitute
    • 5.3.4. Threat of new entrant
    • 5.3.5. Competitive rivalry
  • 5.4. Heat Map Analysis

6. Competitive Landscape

  • 6.1. Global Metaverse In Healthcare Market Manufacturing Base Distribution, Sales Area, Product Type
  • 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Metaverse In Healthcare Market

7. Global Metaverse In Healthcare Market, By Component (USD Million)

  • 7.1. Global Metaverse In Healthcare Market Value Share and Forecast, By Component 2023-2033
  • 7.2. Hardware
  • 7.3. Services
  • 7.4. Software

8. Global Metaverse In Healthcare Market, By Technology (USD Million)

  • 8.1. Global Metaverse In Healthcare Market Value Share and Forecast, By Technology 2023-2033
  • 8.2. AI
  • 8.3. AR/VR
  • 8.4. Block chain
  • 8.5. IoT
  • 8.6. MR

9. Global Metaverse In Healthcare Market, By Application (USD Million)

  • 9.1. Global Metaverse In Healthcare Market Size Value Share and Forecast, By Disease Stage 2023-2033
  • 9.2. Diagnostics,
  • 9.3. Medical Training & Education
  • 9.4. Tele-health

10. Global Metaverse In Healthcare Market, By End User (USD Million)

  • 10.1. Global Metaverse In Healthcare Market Size Value Share and Forecast, By Disease Stage 2023-2033
  • 10.2. Patients
  • 10.3. Payers
  • 10.4. Pharmacy
  • 10.5. Provider

11. Global Metaverse In Healthcare Market, Forecast, 2019-2033 (USD Million)

  • 11.1. Global Metaverse In Healthcare Market Size and Market Share

12. Global Metaverse In Healthcare Market, By Component 2019-2033 (USD Million)

  • 12.1. Global Metaverse In Healthcare Market Size and Market Share, By Component (2019-2026)
  • 12.2. Global Metaverse In Healthcare Market Size and Market Share, By Component (2027-2033)

13. Global Metaverse In Healthcare Market, By Technology 2019-2033 (USD Million)

  • 13.1. Global Metaverse In Healthcare Market Size and Market Share, By Technology (2019-2026)
  • 13.2. Global Metaverse In Healthcare Market Size and Market Share, By Technology (2027-2033)

14. Global Metaverse In Healthcare Market, By Application, 2019-2033 (USD Million)

  • 14.1. Global Metaverse In Healthcare Market Size and Market Share, By Application (2019-2026)
  • 14.2. Global Metaverse In Healthcare Market Size and Market Share, By Application (2027-2033)

15. Global Metaverse In Healthcare Market, By End User 2019-2033 (USD Million)

  • 15.1. Global Metaverse In Healthcare Market Size and Market Share, By End User (2019-2026)
  • 15.2. Global Metaverse In Healthcare Market Size and Market Share, By End User (2027-2033

16. Global Metaverse In Healthcare Market, By Region, 2019-2033 (USD Million)

  • 16.1. Global Metaverse In Healthcare Market Size and Market Share, By Region (2019-2026)
  • 16.2. Global Metaverse In Healthcare Market Size and Market Share, By Region (2027-2033)
  • 16.3. Asia-Pacific
    • 16.3.1. Australia
    • 16.3.2. China
    • 16.3.3. India
    • 16.3.4. Japan
    • 16.3.5. South Korea
    • 16.3.6. Rest of Asia-Pacific
  • 16.4. Europe
    • 16.4.1. France
    • 16.4.2. Germany
    • 16.4.3. Italy
    • 16.4.4. Spain
    • 16.4.5. United Kingdom
    • 16.4.6. Rest of Europe
  • 16.5. Middle East and Africa
    • 16.5.1. Kingdom of Saudi Arabia
    • 16.5.2. United Arab Emirates
    • 16.5.3. Rest of Middle East & Africa
  • 16.6. North America
    • 16.6.1. Canada
    • 16.6.2. Mexico
    • 16.6.3. United States
  • 16.7. Latin America
    • 16.7.1. Argentina
    • 16.7.2. Brazil
    • 16.7.3. Rest of Latin America

17. Company Profile

  • 17.1. Brain lab
    • 17.1.1. Company details
    • 17.1.2. Financial outlook
    • 17.1.3. Product summary
    • 17.1.4. Recent developments
  • 17.2. Medtronic PLC
    • 17.2.1. Company details
    • 17.2.2. Financial outlook
    • 17.2.3. Product summary
    • 17.2.4. Recent developments
  • 17.3. Meta Platforms
    • 17.3.1. Company details
    • 17.3.2. Financial outlook
    • 17.3.3. Product summary
    • 17.3.4. Recent developments
  • 17.4. Microsoft Corporation
    • 17.4.1. Company details
    • 17.4.2. Financial outlook
    • 17.4.3. Product summary
    • 17.4.4. Recent developments
  • 17.5. Nvidia Corporation
    • 17.5.1. Company details
    • 17.5.2. Financial outlook
    • 17.5.3. Product summary
    • 17.5.4. Recent developments
  • 17.6. Roblox Corporation
    • 17.6.1. Company details
    • 17.6.2. Financial outlook
    • 17.6.3. Product summary
    • 17.6.4. Recent developments
  • 17.7. Sesame
    • 17.7.1. Company details
    • 17.7.2. Financial outlook
    • 17.7.3. Product summary
    • 17.7.4. Recent developments
  • 17.8. Siemens Healthineers
    • 17.8.1. Company details
    • 17.8.2. Financial outlook
    • 17.8.3. Product summary
    • 17.8.4. Recent developments
  • 17.9. Veyond Metaverse
    • 17.9.1. Company details
    • 17.9.2. Financial outlook
    • 17.9.3. Product summary
    • 17.9.4. Recent developments
  • 17.10. Zimmer Biomet Holdings
    • 17.10.1. Company details
    • 17.10.2. Financial outlook
    • 17.10.3. Product summary
    • 17.10.4. Recent developments
  • 17.11. Others

18. List of Abbreviations

19. Reference Links

20. Conclusion

21. Research Scope